1. Design and Rationale of the GAUSS‐2 Study Trial: A Double‐Blind, Ezetimibe‐Controlled Phase 3 Study of the Efficacy and Tolerability of Evolocumab (AMG 145) in Subjects With Hypercholesterolemia Who Are Intolerant of Statin Therapy. Issue 3 (29th January 2014) Authors: Cho, Leslie; Rocco, Michael; Colquhoun, David; Sullivan, David; Rosenson, Robert S.; Dent, Ricardo; Xue, Allen; Scott, Rob; Wasserman, Scott M; Stroes, Erik Journal: Clinical cardiology Issue: Volume 37:Issue 3(2014:Mar.) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Light out of deep darkness: a pioneer's adventures in Egypt, 1903–1923, and his campaign against the plague of ophthalmia. Issue 4 (25th July 2014) Authors: Scott, Rob Journal: Journal of the Royal Army Medical Corps Issue: Volume 161:Issue 4(2015) Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rationale and Design of LAPLACE‐2: A Phase 3, Randomized, Double‐Blind, Placebo‐ and Ezetimibe‐Controlled Trial Evaluating the Efficacy and Safety of Evolocumab in Subjects With Hypercholesterolemia on Background Statin Therapy. Issue 4 (30th January 2014) Authors: Robinson, Jennifer G.; Rogers, William J.; Nedergaard, Bettina S.; Fialkow, Jonathan; Neutel, Joel M.; Ramstad, David; Somaratne, Ransi; Legg, Jason C.; Nelson, Patric; Scott, Rob; Wasserman, Scott M.; Weiss, Robert Journal: Clinical cardiology Issue: Volume 37:Issue 4(2014:Apr.) Page Start: 195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗